Les nouveaux auto-anticorps dans les neuropathies dysimmunes

Ogata, 2015, Characterization of IgG4 anti-neurofascin 155 antibody-positive polyneuropathy, Ann Clin Transl Neurol, 2, 960, 10.1002/acn3.248 Querol, 2014, Neurofascin IgG4 antibodies in CIDP associate with disabling tremor and poor response to IVIg, Neurology, 82, 879, 10.1212/WNL.0000000000000205 Miura, 2015, Contactin 1 IgG4 associates to chronic inflammatory demyelinating polyneuropathy with sensory ataxia, Brain, 138, 1484, 10.1093/brain/awv054 Devaux, 2016, Neurofascin-155 IgG4 in chronic inflammatory demyelinating polyneuropathy, Neurology, 86, 800, 10.1212/WNL.0000000000002418 Querol, 2013, Antibodies to contactin-1 in chronic inflammatory demyelinating polyneuropathy, Ann Neurol, 73, 370, 10.1002/ana.23794 Vallat, 2017, Paranodal lesions in chronic inflammatory demyelinating polyneuropathy associated with anti-neurofascin 155 antibodies, Neuromuscul Disord, 27, 290, 10.1016/j.nmd.2016.10.008 Koike, 2017, Paranodal dissection in chronic inflammatory demyelinating polyneuropathy with anti-neurofascin-155 and anti-contactin-1 antibodies, J Neurol Neurosurg Psychiatry, 88, 465, 10.1136/jnnp-2016-314895 Doppler, 2015, Destruction of paranodal architecture in inflammatory neuropathy with anti-contactin-1 autoantibodies, J Neurol Neurosurg Psychiatry, 86, 720, 10.1136/jnnp-2014-309916 Querol, 2015, Rituximab in treatment-resistant CIDP with antibodies against paranodal proteins, Neurol Neuroimmunol Neuroinflammation, 2, e149, 10.1212/NXI.0000000000000149 Kadoya, 2016, IgG4 anti-neurofascin155 antibodies in chronic inflammatory demyelinating polyradiculoneuropathy: clinical significance and diagnostic utility of a conventional assay, J Neuroimmunol, 301, 16, 10.1016/j.jneuroim.2016.10.013 Manso, 2016, Contactin-1 IgG4 antibodies cause paranode dismantling and conduction defects, Brain, 139, 1700, 10.1093/brain/aww062 Delmont, 2017, Autoantibodies to nodal isoforms of neurofascin in chronic inflammatory demyelinating polyneuropathy, Brain, 140 Notturno, 2014, Autoantibodies to neurofascin-186 and gliomedin in multifocal motor neuropathy, J Neuroimmunol, 276, 207, 10.1016/j.jneuroim.2014.09.001 Mathey, 2017, Autoantibody responses to nodal and paranodal antigens in chronic inflammatory neuropathies, J Neuroimmunol, 309, 41, 10.1016/j.jneuroim.2017.05.002 Doppler, 2015, Contactin-1 and Neurofascin-155/-186 are not targets of auto-antibodies in multifocal motor neuropathy, PLoS One, 10, e0134274, 10.1371/journal.pone.0134274 Doppler, 2016, Auto-antibodies to contactin-associated protein 1 (Caspr) in two patients with painful inflammatory neuropathy, Brain, 139, 2617, 10.1093/brain/aww189 Plomp, 2009, Pathophysiological actions of neuropathy-related anti-ganglioside antibodies at the neuromuscular junction, J Physiol, 587, 3979, 10.1113/jphysiol.2009.171702 Chiba, 1993, Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller-Fisher syndrome and Guillain-Barré syndrome: clinical and immunohistochemical studies, Neurology, 43, 1911, 10.1212/WNL.43.10.1911 Yuki, 2014, Acute and chronic ataxic neuropathies with disialosyl antibodies: a continuous clinical spectrum and a common pathophysiological mechanism, Muscle Nerve, 49, 629, 10.1002/mus.24192 Wakerley, 2014, Guillain-Barré and Miller-Fisher syndromes – new diagnostic classification, Nat Rev Neurol, 10, 537, 10.1038/nrneurol.2014.138 Taieb, 2015, Proximal conduction block in the pharyngeal-cervical-brachial variant of Guillain-Barré syndrome, Muscle Nerve, 52, 1102, 10.1002/mus.24729 Ho, 1995, Guillain-Barré-syndrome in northern China – relationship to Campylobacter jejuni infection and anti-glycolipid antibodies, Brain, 118, 597, 10.1093/brain/118.3.597 Kuijf, 2005, Diagnostic value of anti-GM1 ganglioside serology and validation of the INCAT-ELISA, J Neurol Sci, 239, 37, 10.1016/j.jns.2005.07.009 Attarian, 2009, Chronic ataxic neuropathies associated with anti-GD1b IgM antibodies: response to IVIg therapy, J Neurol Neurosurg Psychiatry, 81, 61, 10.1136/jnnp.2009.185736 Willison, 2001, The clinical and laboratory features of chronic sensory ataxic neuropathy with anti-disialosyl IgM antibodies, Brain, 124, 1968, 10.1093/brain/124.10.1968 Shahrizaila, 2014, Antibodies to single glycolipids and glycolipid complexes in Guillain-Barré syndrome subtypes, Neurology, 83, 118, 10.1212/WNL.0000000000000577 Halstead, 2016, Microarray screening of Guillain-Barré syndrome sera for antibodies to glycolipid complexes, Neurol Neuroimmunol Neuroinflamm, 3, e284, 10.1212/NXI.0000000000000284 Delmont, 2014, Improving the detection of IgM antibodies against glycolipids complexes of GM1 and Galactocerebroside in multifocal motor neuropathy using glycoarray and ELISA assays, J Neuroimmunol, 278, 159, 10.1016/j.jneuroim.2014.11.001 Nobile-Orazio, 2014, Sensitivity and predictive value of anti-GM1/galactocerebroside IgM antibodies in multifocal motor neuropathy, J Neurol Neurosurg Psychiatry, 85, 754, 10.1136/jnnp-2013-305755 Yuki, 2004, Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barré syndrome, Proc Natl Acad Sci U S A, 101, 11404, 10.1073/pnas.0402391101 Uncini, 2013, Nodo-paranodopathy: beyond the demyelinating and axonal classification in anti-ganglioside antibody-mediated neuropathies, Clin Neurophysiol, 124, 1928, 10.1016/j.clinph.2013.03.025 Svahn, 2017, Anti-MAG antibodies in 202 patients: clinicopathological and therapeutic features, J Neurol Neurosurg Psychiatry Magy, 2015, Heterogeneity of polyneuropathy associated with anti-MAG antibodies, J Immunol Res, 2015, 450391, 10.1155/2015/450391 Kuijf, 2009, Detection of anti-MAG antibodies in polyneuropathy associated with IgM monoclonal gammopathy, Neurology, 73, 688, 10.1212/WNL.0b013e3181b59a80 Quarles, 2007, Myelin-associated glycoprotein (MAG): past, present and beyond, J Neurochem, 100, 1431 Herrendorff, 2017, Selective in vivo removal of pathogenic anti-MAG autoantibodies, an antigen-specific treatment option for anti-MAG neuropathy, Proc Natl Acad Sci U S A, 114, E3689, 10.1073/pnas.1619386114 Antoine, 2015, Antifibroblast growth factor receptor 3 antibodies identify a subgroup of patients with sensory neuropathy, J Neurol Neurosurg Psychiatry, 86, 1347, 10.1136/jnnp-2014-309730 Antoine, 2013, Treatment options in paraneoplastic disorders of the peripheral nervous system, Curr Treat Options Neurol, 15, 210, 10.1007/s11940-012-0210-9 Giannotta, 2015, Anti-sulfatide IgM antibodies in peripheral neuropathy: to test or not to test?, Eur J Neurol, 22, 879, 10.1111/ene.12658